Peter Weinstein

Peter D. Weinstein, Ph.D., J.D., is the CEO of Circurna, Inc., bringing over 30 years of experience across biotech business, law, R&D, intellectual property, and fundraising. He began as a scientist with a Ph.D. from the University of Pennsylvania and held research fellowships at the NIH and USAMRIID before transitioning to law, where he worked at the USPTO and top firms including Goodwin Procter and Fish & Richardson. As head of Baxter’s hemophilia programs, he built patent portfolios that generated hundreds of millions in licensing revenue and helped lead two therapies—Adenovate? and Vonvendi?—from bench to FDA/EMEA approval. He later founded Entralta, a boutique legal and business consultancy that served over 350 startups and small companies. Dr. Weinstein’s unique blend of scientific, legal, and business expertise enables Circurna to advance toward clinical milestones rapidly and cost-effectively.